Pharmacokinetics, therapeutic monitoring and explicit calculation models
Follow the drug through the body
Absorption, distribution, metabolism and excretion influence concentration over time. Bioavailability describes the relevant fraction reaching systemic circulation under a stated comparison, while apparent distribution volume relates an amount to a measured concentration. Distribution volume is not a literal anatomical container. Clearance describes removal relative to concentration and has volume-per-time units; confusing clearance with an amount removed each hour creates calculation errors.
State the model before calculating
For a supplied one-compartment first-order model, half-life, clearance and distribution volume have defined mathematical relationships. Loading and maintenance quantities answer different questions. A target concentration, unit conversion, salt or active-moiety basis and bioavailability assumption must be explicit before arithmetic is meaningful. A correct model calculation does not establish that the model fits the actual patient or that its result is an authorized dose. Saturable elimination and changing physiology can invalidate a simple proportional adjustment.
Interpret timing and patient context
A concentration collected after a dose has a different meaning from one collected before the next dose. Record actual administration and sampling times, route, formulation and adherence. Steady state is a model property approached over time, not a guarantee that every patient is stable after one fixed number of hours. Albumin, organ function, interacting medicines and the clinical condition can alter interpretation. A total concentration can differ from the clinically relevant free fraction.
Use monitoring to answer the clinical question
Therapeutic monitoring combines exposure information with benefit, harm and the actual indication. A result within a reference target does not prove absence of toxicity, while a result outside it is not always a reason for an automatic identical change. Renal function estimates, body-size conventions and equations have limits and are not freely interchangeable for every medicine or population. Confirm the method required by the current product or validated protocol. This written chapter supports explicit supplied arithmetic and reasoning; it cannot replace clinical assessment, actual drug-specific monitoring procedures or qualified prescribing decisions.